Madrigal Pharmaceuticals Inc (MDGL)
210.08
+6.06
(+2.97%)
USD |
NASDAQ |
May 01, 16:00
210.82
+0.74
(+0.35%)
After-Hours: 20:00
Madrigal Pharmaceuticals Cash and Short Term Investments (Quarterly): 634.13M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 634.13M |
| September 30, 2023 | 232.35M |
| June 30, 2023 | 298.42M |
| March 31, 2023 | 329.48M |
| December 31, 2022 | 358.77M |
| September 30, 2022 | 153.19M |
| June 30, 2022 | 211.77M |
| March 31, 2022 | 219.95M |
| December 31, 2021 | 270.35M |
| September 30, 2021 | 299.14M |
| June 30, 2021 | 323.85M |
| March 31, 2021 | 307.22M |
| December 31, 2020 | 284.15M |
| September 30, 2020 | 335.94M |
| June 30, 2020 | 384.38M |
| March 31, 2020 | 408.51M |
| December 31, 2019 | 439.04M |
| September 30, 2019 | 453.61M |
| June 30, 2019 | 466.40M |
| March 31, 2019 | 477.82M |
| December 31, 2018 | 483.72M |
| September 30, 2018 | 488.54M |
| June 30, 2018 | 490.30M |
| March 31, 2018 | 182.82M |
| December 31, 2017 | 191.53M |
| Date | Value |
|---|---|
| September 30, 2017 | 62.14M |
| June 30, 2017 | 67.17M |
| March 31, 2017 | 40.13M |
| December 31, 2016 | 40.50M |
| September 30, 2016 | 39.56M |
| June 30, 2016 | 43.02M |
| March 31, 2016 | 52.04M |
| December 31, 2015 | 0.3062M |
| September 30, 2015 | 88.25M |
| June 30, 2015 | 98.33M |
| March 31, 2015 | 76.61M |
| December 31, 2014 | 97.69M |
| September 30, 2014 | 119.28M |
| June 30, 2014 | 112.06M |
| March 31, 2014 | 78.79M |
| December 31, 2013 | 91.48M |
| September 30, 2013 | 53.38M |
| June 30, 2013 | 70.20M |
| March 31, 2013 | 90.39M |
| December 31, 2012 | 100.60M |
| September 30, 2012 | 55.14M |
| June 30, 2012 | 44.66M |
| March 31, 2012 | 57.39M |
| December 31, 2011 | 39.72M |
| September 30, 2011 | 50.66M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
153.19M
Minimum
Sep 2022
634.13M
Maximum
Dec 2023
337.40M
Average
323.85M
Median
Jun 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly and Co | 2.586B |
| Viking Therapeutics Inc | 962.98M |
| Akero Therapeutics Inc | 550.01M |
| 89bio Inc | 578.87M |
| Geron Corp | 333.70M |